OpenAlex
PricingAboutJobs
Log inGet started
Author

S.-Y. Liu

Institution: Guangdong Provincial People's Hospital
Observed institutions: Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital
OpenAlex ID: A5091592097
A comprehensive model of genetic-features predicts outcome of personalized adjuvant treatment in resected EGFR-mutant stage II-IIIA NSCLC: Results from a phase III trial (CTONG 1104-ADJUVANT)
2019 · Y.-L. Wu, S.-Y. Liu, et al. · Annals of Oncology · 5
PDF
LBA2 Phase II study of PD-L1 expression guidance on neoadjuvant (NA) nivolumab (Nivo) monotherapy with or without platinum-doublet chemotherapy in resectable NSCLC
2022 · S.-Y. Liu, S. Dong, et al. · Immuno-Oncology Technology · 3
P1.27-03 Neoadjuvant PD-1 Blockade Plus Platinum-based Chemotherapy for EGFR-mutant NSCLC (CTONG2104): An Interim Analysis
2023 · C. Zhang, D.-C. Yi, et al. · Journal of Thoracic Oncology · 1
PDF
Works count: 3
Citation count: 9
H-index: 2
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms